Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pfizer presents new TGF-beta type II receptor kinase inhibitors

Sep. 21, 2004

New antitumor agents prepared and tested at Dr. Reddy's

Sep. 21, 2004

License termination agreement returns LEP and LED rights to NeoPharm

Sep. 21, 2004

New antitumor agents prepared and tested at Servier

Sep. 20, 2004

Aventis describes cyclic urea-based inhibitors of IGF-1R and other kinases

Sep. 20, 2004

Three series of Src kinase inhibitors presented by AstraZeneca

Sep. 20, 2004

Alfacell licenses antibody from NIH

Sep. 20, 2004

Ziopharm licenses new class of organic arsenicals from M.D. Anderson

Sep. 17, 2004

Antigen Express collaborates on melanoma vaccine development

Sep. 17, 2004

CA4P investigated in combination with cisplatin in phase I cervical cancer study

Sep. 17, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...